Healthline Holdings, Inc. – Trademark Portfolio
Entity Type: 03
Healthline Holdings, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PSYCHCENTRAL. The owner is based in San Francisco, CA.
660 Third Street
San Francisco, CA 94107
Showing of trademarks Trademarks
Trademark Classifications
Healthline Holdings, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Legal services; security services for the protection of property and individuals
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Healthline Holdings, Inc. have?
Healthline Holdings, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Healthline Holdings, Inc. file in?
Healthline Holdings, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Healthline Holdings, Inc.'s most well-known trademarks?
Healthline Holdings, Inc.'s registered trademark portfolio includes well-known marks such as PSYCHCENTRAL. These are among 1 currently registered trademark in the portfolio.
What is Healthline Holdings, Inc.'s trademark registration success rate?
Healthline Holdings, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.